Sign up for free insights newsletter
66

BrainAurora Med Tech Ltd

6681Hong Kong Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

HK$4.03
-2.42%
End of day
Market Cap

$5.46B

P/E Ratio

N/A

Employees

174

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino23.551.13-1.60-1.55-0.660.77
Calmar3.56-2.07-1.41-0.47-0.51
Sharpe6.610.76-1.26-1.10-0.38-0.13
Omega2.951.190.650.740.981.01
Martin6.90-2.63-2.17-0.80-0.48
Ulcer0.725.6431.5733.1739.6529.18

BrainAurora Med Tech Ltd (6681) Price Performance

BrainAurora Med Tech Ltd (6681) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at HKD4.03, down 2.42% from the previous close.

Over the past year, 6681 has traded between a low of HKD3.92 and a high of HKD11.79. The stock has lost 33.2% over this period. It is currently 65.8% below its 52-week high.

BrainAurora Med Tech Ltd has a market capitalization of $5.46B.

About BrainAurora Med Tech Ltd

BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. The company develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Basic Cognitive Testing Software, an assessment of patients for basic cognitive capacity; Cognitive Ability Supplemental screening and assessment software, a solution designed to facilitate healthcare professionals assessment of patients; and Dyslexia Supplemental Screening and Assessment Software, a solution designed to facilitate the assessment of risk of developmental dyslexia in children. It also develops covid-19 induced cognitive impairment assessment and recovery training software; ADHD assessment and treatment software; quantitative cognitive assessment software for depression; depression treatment software; and cognitive impairment assessment software and cognitive impairment treatment software solutions. In addition, the company provides marketing services. BrainAurora Medical Technology Limited was founded in 2012 and is headquartered in Shaoxing, China.

Compare BrainAurora Med Tech Ltd

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
Hong Kong Stock Exchange
Currency
HKD
Country
Hong Kong

Financial Metrics

Revenue (TTM)
$220.05M
EBITDA
$-273,407,008
Profit Margin
-143.09%
EPS (TTM)
-0.21
Book Value
0.09

Technical Indicators

52 Week High
HK$17.79
52 Week Low
HK$3.77
50 Day MA
HK$4.40
200 Day MA
HK$5.97
Beta
N/A

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
24.81
Price/Book
48.53
Enterprise Value
$5.57B